Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 477, doi. 10.1007/s40259-024-00667-0
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2024 AND VI 38 AND IP 4
Results: 10
1
2
Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 601, doi. 10.1007/s40259-024-00666-1
- By:
- Publication type:
- Article
3
Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 511, doi. 10.1007/s40259-024-00665-2
- By:
- Publication type:
- Article
4
Postmarketing Reports of Incomplete Dosing-Related Complications with Self-Injected PCSK9 Inhibitors: A Descriptive Study and Disproportionality Analysis.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 589, doi. 10.1007/s40259-024-00664-3
- By:
- Publication type:
- Article
5
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 557, doi. 10.1007/s40259-024-00663-4
- By:
- Publication type:
- Article
6
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 571, doi. 10.1007/s40259-024-00662-5
- By:
- Publication type:
- Article
7
Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 527, doi. 10.1007/s40259-024-00661-6
- By:
- Publication type:
- Article
8
Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 487, doi. 10.1007/s40259-024-00660-7
- By:
- Publication type:
- Article
9
Barriers and Enablers Affecting the Uptake of Biosimilar Medicines Viewed Through the Lens of Actor Network Theory: A Systematic Review.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 541, doi. 10.1007/s40259-024-00659-0
- By:
- Publication type:
- Article
10
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges.
- Published in:
- BioDrugs, 2024, v. 38, n. 4, p. 499, doi. 10.1007/s40259-024-00657-2
- By:
- Publication type:
- Article